ChinaTechSignals

Database

Funding Rounds

551 rounds tracked

UndisclosedSeed
Hemu Intelligentaihardware
3 Sept 2026

Hemu Intelligent specializes in physical AI for mold manufacturing and manufacturing semantic computing, building an AI process brain for mold enterprises to automate the entire manufacturing workflow.

UndisclosedStrategic
LEON ROBOTairobotics
3 Sept 2026

立昂机器人是一家专注于空间智能与具身智能的科技创新型企业,深耕具身机器人在轻工业领域的落地应用,提供空间智能控制器、具身智能控制器及行业机器人解决方案。

UndisclosedSeries A
Youbaote Intelligent Robotroboticsai
3 Sept 2026

Youbaote specializes in the R&D of legged bionic robots, humanoid robots, and hydraulic special robots, providing integrated solutions for intelligent robot applications.

Orient Securities Capital, Jinan Xianxing Investment Group, Zibo High-Tech Zone Venture Capital

Source →
UndisclosedSeries A
KylinWaybiotechsaas
3 Sept 2026

KylinWay is a national high-tech enterprise focusing on the R&D, production, and industrial application of hydrogen molecular medical new materials, providing one-stop raw material and technical solutions for cosmetics, hygiene, and medical dressing sectors.

Tiantu Capital (Beauty Leading Fund)

Source →
UndisclosedAngel
AIPheraibiotech
3 Sept 2026

AIPher is an AI-native drug discovery company utilizing artificial intelligence and drug foundation models like DrugCLIP to redefine innovative drug R&D.

Xianghe Capital

Source →
UndisclosedAngel
Violoopaihardware
2 Sept 2026

Violoop develops a palm-sized USB device with screen-aware AI hardware that reads the user's entire screen to build a proactive AI assistant.

UndisclosedPre-A
Dingxi Zhichuang
2 Sept 2026
UndisclosedSeries B
Medifabiotechhealthtech
2 Sept 2026

Medifa is a biotechnology company focused on the independent innovation, development, and scaled production of next-generation fully bio-based and naturally biodegradable PHA biomaterials and high-end downstream derivatives for industrial and medical applications.

China Taiping Insurance Group (China Taiping Innovation), Baiyun Fund

Source →
UndisclosedAngel
Xinghui Zhongyueaibiotech
2 Sept 2026

Xinghui Zhongyue develops non-invasive brain-computer interface technologies and wearable BCI devices, providing auxiliary diagnosis, rehabilitation, and AI-driven EEG emotional assessment solutions for psychiatric disorders and neurological conditions.

Wuhan Venture Capital, Hongshan Capital

Source →
UndisclosedSeries C
Bangshun Pharmaceuticalbiotech
2 Sept 2026

Bangshun Pharmaceutical is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for oncology and autoimmune diseases.

Kefacapital, SVIC +more

Source →
UndisclosedSeries B
Yuce Biobiotechhealthtech
2 Sept 2026

Yuce Bio is an innovative enterprise focusing on precise diagnosis of neurological blood biomarkers based on single-molecule immunoassay technology, promoting clinical and health management applications.

Jiangsu Taizhou Greater Health Advanced Manufacturing Industry Special Mother Fund, Shanghai Univ-Bio, Leader Venture Capital

Source →
UndisclosedSeed
Wavelet Intelligenceaihardware
1 Sept 2026

Wavelet Intelligence is an AI for IC design innovation company that builds next-generation AI-driven EDA (Electronic Design Automation) tools and intelligent platforms to lower chip design barriers and shorten R&D cycles.

UndisclosedSeries A
Xuanchuang Roboticsairobotics
1 Sept 2026

Xuanchuang Robotics is a special industrial embodied AI enterprise founded in December 2022, focusing on the R&D and application of special embodied intelligent robots for high-risk industries such as oil, chemical, and nuclear power.

Guangyang Co., Ltd., West Lake Innovation Investment

Source →
$445MSeries B
Vastai
1 Sept 2026

VAST is an artificial intelligence company focused on 3D native intelligence, enabling users to create and run interactive, dynamically evolving 3D worlds.

Yanqu Game, Thundersoft +more

Source →
UndisclosedSeries A
Bowang Sensingroboticshardware
1 Sept 2026

Bowang Sensing specializes in the R&D and production of inductive encoders, serving as a core component supplier for industrial automation and robotics.

Dawu Venture Capital, Jiayi Venture Capital +more

Source →
UndisclosedStrategic
Haofeng Medicalhealthtech
1 Sept 2026

Haofeng Medical is a third-class interventional medical device CDMO platform company that provides global manufacturers with comprehensive services from product R&D and pre-registration production to post-market contract manufacturing.

Huayin Financial Investment

Source →
$59MSeries B
ImmuneOnco Biopharmabiotech
31 Aug 2026
$15MSeed
Wosheng Biomedicinebiotech
31 Aug 2026

Wosheng Biomedicine is an innovative biopharmaceutical company focused on next-generation protein degradation technology, dedicated to overcoming unmet clinical treatment needs in the central nervous system field.

Lilly Asia Ventures, BioTrack Capital

Source →
$59MSeries B
SinoCellTechbiotechhealthtech
31 Aug 2026

Xianbo Biology is a clinical-stage biotechnology company focusing on next-generation cell therapy platforms including universal CAR-NK, in vivo CAR-T, and multi-targeted solid tumor CAR-T.

Futen Capital, Cenova Capital, Zhangke Herun, Yuanhe Holdings +more

Source →
UndisclosedSeries A
Xianyan Therapeuticsbiotech
31 Aug 2026

Xianyan Therapeutics focuses on the R&D of oligonucleotide drugs, having built proprietary core technology platforms for small nucleic acid drug delivery and interference, with pipelines targeting cardiovascular and metabolic diseases.

HighLight Capital

Source →